T1	CHEM 11 20	estatinas
#1	AnnotatorNotes T1	C0075191; statine; Amino Acid, Peptide, or Protein | C0360714; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organic Chemical · Pharmacologic Substance
T2	CHEM 23 37	antiagregantes
#2	AnnotatorNotes T2	C0085826; Antiplatelet Agents; Pharmacologic Substance
T3	ANAT 92 102	endotelial
#3	AnnotatorNotes T3	C0014257; Endothelium; Tissue
T4	DISO 109 133	enfermedad renal crónica
#4	AnnotatorNotes T4	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T5	DISO 179 206	insuficiencia renal crónica
#5	AnnotatorNotes T5	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T6	DISO 208 211	IRC
#6	AnnotatorNotes T6	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T7	DISO 248 273	enfermedad cardiovascular
#7	AnnotatorNotes T7	C0007222; Cardiovascular Diseases; Disease or Syndrome
T8	DISO 296 299	IRC
#8	AnnotatorNotes T8	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T9	DISO 333 354	disfunción endotelial
#9	AnnotatorNotes T9	C0856169; Endothelial dysfunction; Disease or Syndrome
T10	CHEM 384 392	fármacos
#10	AnnotatorNotes T10	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T11	CHEM 509 518	estatinas
#11	AnnotatorNotes T11	C0075191; statine; Amino Acid, Peptide, or Protein | C0360714; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organic Chemical · Pharmacologic Substance
T12	CHEM 525 552	antiagregantes plaquetarios
#12	AnnotatorNotes T12	C0085826; Antiplatelet Agents; Pharmacologic Substance
T13	ANAT 568 595	microvesículas endoteliales
#13	AnnotatorNotes T13	C3156618; Endothelial Cell-Derived Microparticle; Cell Component (?)
T14	DISO 627 648	disfunción endotelial
#14	AnnotatorNotes T14	C0856169; Endothelial dysfunction; Disease or Syndrome
T15	PROC 673 692	Estudio transversal
#15	AnnotatorNotes T15	C0010362; Cross-Sectional Studies; Research Activity
T16	ANAT 805 813	vascular
#16	AnnotatorNotes T16	C0005847; Blood Vessel; Body Part, Organ, or Organ Component | C1283786; Entire blood vessel; Body Part, Organ, or Organ Component
T17	ANAT 814 824	endotelial
#17	AnnotatorNotes T17	C0014257; Endothelium; Tissue
T18	DISO 986 998	comorbilidad
#18	AnnotatorNotes T18	C1275743; Co-morbid conditions; Finding
T19	PROC 1001 1025	estrategias terapéuticas
#19	AnnotatorNotes T19	C0679624; medical treatment method; Therapeutic or Preventive Procedure (?)
T20	DISO 1076 1079	IRC
#20	AnnotatorNotes T20	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T21	ANAT 1044 1047	MVE
#21	AnnotatorNotes T21	C3156618; Endothelial Cell-Derived Microparticle; Cell Component (?)
T22	CHEM 1224 1233	estatinas
#22	AnnotatorNotes T22	C0075191; statine; Amino Acid, Peptide, or Protein | C0360714; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organic Chemical · Pharmacologic Substance
T23	CHEM 1240 1242	AP
#23	AnnotatorNotes T23	C0085826; Antiplatelet Agents; Pharmacologic Substance
T24	PROC 1281 1295	niveles de MVE
T25	ANAT 1338 1345	séricos
#24	AnnotatorNotes T25	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T26	CHEM 1349 1359	colesterol
#25	AnnotatorNotes T26	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T27	CHEM 1387 1391	AOPP
T28	DISO 1444 1447	IRC
#26	AnnotatorNotes T28	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T29	PROC 1516 1530	niveles de MVE
T30	DISO 1481 1484	IRC
#27	AnnotatorNotes T30	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T31	PROC 1548 1559	tratamiento
#28	AnnotatorNotes T31	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T32	DISO 714 717	IRC
#29	AnnotatorNotes T32	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T33	CHEM 1778 1787	estatinas
#30	AnnotatorNotes T33	C0075191; statine; Amino Acid, Peptide, or Protein | C0360714; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organic Chemical · Pharmacologic Substance
T34	DISO 81 102	disfunción endotelial
#31	AnnotatorNotes T34	C0856169; Endothelial dysfunction; Disease or Syndrome
T35	ANAT 120 125	renal
#32	AnnotatorNotes T35	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T36	ANAT 193 198	renal
#33	AnnotatorNotes T36	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T37	ANAT 259 273	cardiovascular
#34	AnnotatorNotes T37	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T38	ANAT 344 354	endotelial
#35	AnnotatorNotes T38	C0014257; Endothelium; Tissue
T39	ANAT 1527 1530	MVE
#36	AnnotatorNotes T39	C3156618; Endothelial Cell-Derived Microparticle; Cell Component (?)
T40	ANAT 540 552	plaquetarios
#37	AnnotatorNotes T40	C0005821; Blood Platelets; Cell
T41	CHEM 554 556	AP
#38	AnnotatorNotes T41	C0085826; Antiplatelet Agents; Pharmacologic Substance
T42	ANAT 638 648	endotelial
#39	AnnotatorNotes T42	C0014257; Endothelium; Tissue
T43	PROC 881 885	AOPP
T44	ANAT 1215 1218	MVE
#40	AnnotatorNotes T44	C3156618; Endothelial Cell-Derived Microparticle; Cell Component (?)
T45	PROC 1330 1365	niveles séricos de colesterol total
#41	AnnotatorNotes T45	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T46	PROC 1367 1369	CT
#42	AnnotatorNotes T46	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T47	CHEM 1564 1573	estatinas
#43	AnnotatorNotes T47	C0075191; statine; Amino Acid, Peptide, or Protein | C0360714; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organic Chemical · Pharmacologic Substance
T48	CHEM 1576 1578	AP
#44	AnnotatorNotes T48	C0085826; Antiplatelet Agents; Pharmacologic Substance
T49	PROC 1677 1688	nivel de CT
#45	AnnotatorNotes T49	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T50	CHEM 1794 1796	AP
#46	AnnotatorNotes T50	C0085826; Antiplatelet Agents; Pharmacologic Substance
T51	ANAT 1292 1295	MVE
#47	AnnotatorNotes T51	C3156618; Endothelial Cell-Derived Microparticle; Cell Component (?)
T52	ANAT 597 600	MVE
#48	AnnotatorNotes T52	C3156618; Endothelial Cell-Derived Microparticle; Cell Component (?)
T53	PROC 767 781	niveles de MVE
T54	ANAT 778 781	MVE
#49	AnnotatorNotes T54	C3156618; Endothelial Cell-Derived Microparticle; Cell Component (?)
T55	PROC 826 830	FCVE
#50	AnnotatorNotes T55	C2239222; Vascular Endothelial Growth Factor Measurement; Laboratory Procedure
T56	PROC 783 824	factor de crecimiento vascular endotelial
#51	AnnotatorNotes T56	C2239222; Vascular Endothelial Growth Factor Measurement; Laboratory Procedure
T57	PROC 834 879	productos avanzados de oxidación de proteínas
T58	PROC 1532 1536	FCVE
#52	AnnotatorNotes T58	C2239222; Vascular Endothelial Growth Factor Measurement; Laboratory Procedure
T59	PROC 1539 1543	AOPP
T60	PROC 1298 1302	FCVE
#53	AnnotatorNotes T60	C2239222; Vascular Endothelial Growth Factor Measurement; Laboratory Procedure
T61	PROC 1376 1391	niveles de AOPP
T62	PROC 1394 1398	FCVE
#54	AnnotatorNotes T62	C2239222; Vascular Endothelial Growth Factor Measurement; Laboratory Procedure
T63	Duration 126 133	crónica
#55	AnnotatorNotes T63	C0205191; chronic; Temporal Concept
T64	LIVB 165 174	pacientes
#56	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T65	Duration 199 206	crónica
#57	AnnotatorNotes T65	C0205191; chronic; Temporal Concept
T66	Spec_cue 226 235	riesgo de
T67	LIVB 282 291	pacientes
#58	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T68	LIVB 413 422	pacientes
#59	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T70	LIVB 700 709	pacientes
#60	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T71	PHYS 919 930	circulación
#61	AnnotatorNotes T71	C0005775; Blood Circulation; Physiologic Function
T72	LIVB 1062 1071	pacientes
#62	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T75	LIVB 1430 1439	pacientes
#63	AnnotatorNotes T75	C0030705; Patients; Patient or Disabled Group
T76	PHYS 1749 1770	efectos pleiotrópicos
#64	AnnotatorNotes T76	C2936488; Genetic Pleiotropy; Genetic Function
T77	PHYS 793 824	crecimiento vascular endotelial
#65	AnnotatorNotes T77	C1760030; vascular endothelial growth factor activity; Molecular Function
T69	LIVB 727 744	voluntarios sanos
#66	AnnotatorNotes T69	C1708335; Healthy Volunteers; Population Group
T78	CHEM 870 879	proteínas
#67	AnnotatorNotes T78	C0033684; Proteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T79	LIVB 1112 1121	controles
#68	AnnotatorNotes T79	C0009932; Control Groups; Group
T73	LIVB 1454 1463	controles
#69	AnnotatorNotes T73	C0009932; Control Groups; Group
T74	LIVB 1632 1641	controles
#70	AnnotatorNotes T74	C0009932; Control Groups; Group
T80	PHYS 857 879	oxidación de proteínas
#71	AnnotatorNotes T80	C1159301; Protein oxidation; Molecular Function
A1	Assertion T7 Speculated
R1	Speculation Arg1:T66 Arg2:T7	
T81	Neg_cue 423 425	no
T82	CONC 426 436	se conocen
A2	Assertion T82 Negated
#72	AnnotatorNotes T82	C0205309; Known; Qualitative Concept
R2	Negation Arg1:T81 Arg2:T82	
T83	Neg_cue 1399 1401	no
T84	Quantifier_or_Qualifier 1409 1419	diferentes
#73	AnnotatorNotes T84	C1705242; Different; Qualitative Concept
R3	Negation Arg1:T83 Arg2:T84	
A3	Assertion T84 Negated
T85	Observation 52 102	cambios en los marcadores de disfunción endotelial
R4	Location_of Arg1:T3 Arg2:T34	
R5	Location_of Arg1:T35 Arg2:T4	
R6	Has_Duration_or_Interval Arg1:T4 Arg2:T63	
R7	Overlap Arg1:T85 Arg2:T4	
R8	Overlap Arg1:T34 Arg2:T4	
R9	Overlap Arg1:T2 Arg2:T85	
R10	Overlap Arg1:T1 Arg2:T85	
R11	Location_of Arg1:T36 Arg2:T5	
R12	Location_of Arg1:T36 Arg2:T6	
R13	Has_Duration_or_Interval Arg1:T5 Arg2:T65	
R14	Experiences Arg1:T64 Arg2:T5	
R15	Experiences Arg1:T64 Arg2:T6	
R16	Experiences Arg1:T64 Arg2:T7	
R17	Location_of Arg1:T37 Arg2:T7	
R18	Before Arg1:T5 Arg2:T7	
R19	Has_Duration_or_Interval Arg1:T6 Arg2:T65	
R20	Experiences Arg1:T67 Arg2:T8	
R21	Location_of Arg1:T38 Arg2:T9	
R22	Overlap Arg1:T8 Arg2:T9	
R23	Experiences Arg1:T68 Arg2:T9	
R24	Experiences Arg1:T67 Arg2:T9	
R25	Experiences Arg1:T67 Arg2:T10	
R26	Experiences Arg1:T68 Arg2:T10	
T86	Observation 495 501	efecto
#74	AnnotatorNotes T86	C1518681; Outcome of Therapy; Finding (?)
R27	Causes Arg1:T11 Arg2:T86	
R28	Causes Arg1:T12 Arg2:T86	
R29	Causes Arg1:T41 Arg2:T86	
R30	Location_of Arg1:T13 Arg2:T86	
R31	Location_of Arg1:T52 Arg2:T86	
R32	Location_of Arg1:T42 Arg2:T14	
R33	Overlap Arg1:T86 Arg2:T14	
R34	Experiences Arg1:T70 Arg2:T32	
T87	Quantifier_or_Qualifier 718 722	3b-4
R35	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T87	
R36	Location_of Arg1:T54 Arg2:T53	
R37	Location_of Arg1:T16 Arg2:T77	
R38	Location_of Arg1:T17 Arg2:T77	
R40	Location_of Arg1:T16 Arg2:T56	
R41	Location_of Arg1:T17 Arg2:T56	
R42	Location_of Arg1:T17 Arg2:T55	
R43	Location_of Arg1:T16 Arg2:T55	
T88	CONC 946 957	correlación
#75	AnnotatorNotes T88	C1707520; Correlation; Qualitative Concept
R51	Experiences Arg1:T72 Arg2:T20	
T90	CONC 1174 1185	correlación
#77	AnnotatorNotes T90	C1707520; Correlation; Qualitative Concept
R54	Location_of Arg1:T25 Arg2:T45	
R55	Location_of Arg1:T25 Arg2:T46	
R56	Experiences Arg1:T75 Arg2:T28	
R57	Experiences Arg1:T75 Arg2:T62	
R58	Experiences Arg1:T75 Arg2:T61	
R60	Location_of Arg1:T39 Arg2:T29	
R61	Used_for Arg1:T47 Arg2:T31	
R62	Used_for Arg1:T48 Arg2:T31	
T93	Observation 1649 1655	efecto
R63	Causes Arg1:T31 Arg2:T93	
#80	AnnotatorNotes T93	C1518681; Outcome of Therapy; Finding (?)
T94	Result_or_Value 1186 1194	negativa
R65	Has_Result_or_Value Arg1:T90 Arg2:T94	
T95	Observation 1709 1718	hallazgos
#81	AnnotatorNotes T95	C0243095; Finding; Finding
R66	Causes Arg1:T95 Arg2:T76	
R67	Causes Arg1:T33 Arg2:T76	
R68	Causes Arg1:T50 Arg2:T76	
R81	Experiences Arg1:T73 Arg2:T62	
R82	Experiences Arg1:T73 Arg2:T61	
T96	Result_or_Value 1579 1588	normaliza
#82	AnnotatorNotes T96	C0459422; Normal result; Finding | C0586624; Normal laboratory finding; Finding
R83	Causes Arg1:T31 Arg2:T96	
R39	Has_Quantifier_or_Qualifier Arg1:T61 Arg2:T84	
R44	Has_Quantifier_or_Qualifier Arg1:T62 Arg2:T84	
R45	Experiences Arg1:T74 Arg2:T49	
#76	AnnotatorNotes T27	C1976991; Advanced Oxidation Protein Products; Organic Chemical
A4	Experiencer T64 Patient
A5	Experiencer T67 Patient
A6	Experiencer T68 Patient
A7	Experiencer T70 Patient
A8	Experiencer T69 Other
A9	Experiencer T72 Patient
A10	Experiencer T79 Other
A11	Experiencer T73 Other
A12	Experiencer T75 Patient
A13	Experiencer T74 Other
